“I Will Make UPC Great Again!”—UPC Presidential Hopeful Othieno Vows as He Praises Obote’s Legacy A Bright Future for UPC Appearing on the NBS political program ‘People and Power’ yesterday, Joseph Othieno, a candidate for the Uganda People’s Congress (UPC) presidency, painted a picture of the party’s historical journey and his role in shaping its…
Main Street Financial Services Corp. Implements Dividend Reinvestment Plan Introduction On October 7, 2024, Main Street Financial Services Corp. (OTCQX:MSWV) announced the implementation of a Dividend Reinvestment Plan (DRIP) as part of the Computershare Investment Plan. This new plan will offer eligible shareholders the opportunity to automatically reinvest their dividends in reinvestment shares. Details of…
Analog Devices Launches CodeFusion Studio and Developer Portal Simplified and Efficient Embedded Software Development at the Intelligent Edge By: [Your Name] Professionally, educated, profit-focused, and intense, Analog Devices has taken a significant leap forward in the world of embedded software development with the launch of CodeFusion Studio™ and a new Developer Portal. These new offerings…
Welcome to Galecto, Inc.: Where Innovation Meets Impact Exciting News from Galecto, Inc. On October 7, 2024, Galecto, Inc. made a groundbreaking announcement that is sure to shake up the world of biotechnology. The clinical-stage company, known for its focus on developing novel treatments for cancer and fibrosis, revealed that it will be shifting its…
Quantum BioPharma Ltd. Launches new Beverage Product, unbuzzd™ Toronto, Ontario–(Newsfile Corp. – October 7, 2024) – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (“Quantum BioPharma”) provides an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu” or the “Company”) Quantum BioPharma Ltd. has recently announced the launch of…
Welcome to our Blog Post! Inozyme Pharma, Inc. Appoints Erik Harris to its Board of Directors Boston, Oct. 07, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, today announced the appointment of…
Exciting News in the Fight Against Acute Myeloid Leukemia Live Webcast Discussion with Key Opinion Leaders Recently, Moleculin Biotech, Inc. announced that they will be hosting a virtual event featuring internationally renowned Acute Myeloid Leukemia (AML) Key Opinion Leaders. This live webcast will focus on the ongoing progress of the pivotal, adaptive Phase 3 clinical…
Cutting-Edge Cryoablation Technology Takes Center Stage at EUSOBI 2024 Revolutionary Results in the Fight Against Breast Cancer Award-Winning Presentation by Dr. Kenneth Tomkovich It was a momentous occasion at the European Society of Breast Imaging (EUSOBI) Scientific Meeting and Annual Conference in Lisbon, Portugal. Co-Principal Investigator Dr. Kenneth Tomkovich stole the show with his presentation…
